课题基金 / 基金详情

Development of a personalized medicine approach to corticosteroid treatment in IgA nephropathy

Development of a personalized medicine approach to corticosteroid treatment in IgA nephropathy
IgA 肾病皮质类固醇治疗的个性化医疗方法的开发
批准号：
408947
负责人：
Barbour Sean
金额：
$21.34万
依托单位：
Providence Health Care Research Institute (Vancouver, BC)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-09-01 至 2021-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=408947&lang=en
关键词：
Corticosteroid Treatment Decision Analysis Iga Nephropathy Personalized Medicine Precision Medicine Prediction Model

项目摘要

项目成果

Barbour Sean的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
IgA nephropathy (IgAN) is an autoimmune disease that causes kidney failure, affecting 8,000 Canadians annually. Currently, corticosteroid treatment is used to decrease disease progression in patients with high amounts of protein in their urine. However, t
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving cardiovascular risk prediction in patients with glomerular disease
The derivation, validation and implementation of an international risk prediction tool in IgA nephropathy
海外基金